These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
398 related items for PubMed ID: 37933210
1. Guideline-directed medical therapy in severe heart failure with reduced ejection fraction: An analysis from the HELP-HF registry. Tomasoni D, Pagnesi M, Colombo G, Chiarito M, Stolfo D, Baldetti L, Lombardi CM, Adamo M, Maggi G, Inciardi RM, Loiacono F, Maccallini M, Villaschi A, Gasparini G, Montella M, Contessi S, Cocianni D, Perotto M, Barone G, Merlo M, Cappelletti AM, Rosano G, Sinagra G, Pini D, Savarese G, Metra M. Eur J Heart Fail; 2024 Feb; 26(2):327-337. PubMed ID: 37933210 [Abstract] [Full Text] [Related]
2. Effect of heart failure pharmacotherapies in patients with heart failure with mildly reduced ejection fraction. Schupp T, Bertsch T, Reinhardt M, Abel N, Schmitt A, Lau F, Abumayyaleh M, Akin M, Weiß C, Weidner K, Behnes M, Akin I. Eur J Prev Cardiol; 2024 Aug 22; 31(11):1347-1360. PubMed ID: 38513366 [Abstract] [Full Text] [Related]
4. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. Greene SJ, Butler J, Hellkamp AS, Spertus JA, Vaduganathan M, Devore AD, Albert NM, Patterson JH, Thomas L, Williams FB, Hernandez AF, Fonarow GC. J Card Fail; 2022 Mar 22; 28(3):370-384. PubMed ID: 34793971 [Abstract] [Full Text] [Related]
5. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities. Albert NM, Tyson RJ, Hill CL, DeVore AD, Spertus JA, Duffy C, Butler J, Patterson JH, Hernandez AF, Williams FB, Thomas L, Fonarow GC. Am Heart J; 2021 May 22; 235():82-96. PubMed ID: 33497697 [Abstract] [Full Text] [Related]
6. Target Doses of Heart Failure Medical Therapy and Blood Pressure: Insights From the CHAMP-HF Registry. Peri-Okonny PA, Mi X, Khariton Y, Patel KK, Thomas L, Fonarow GC, Sharma PP, Duffy CI, Albert NM, Butler J, Hernandez AF, McCague K, Williams FB, DeVore AD, Patterson JH, Spertus JA. JACC Heart Fail; 2019 Apr 22; 7(4):350-358. PubMed ID: 30738978 [Abstract] [Full Text] [Related]
7. Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013-2020. Karlström P, Pivodic A, Dahlström U, Fu M. Clin Res Cardiol; 2024 Sep 22; 113(9):1355-1368. PubMed ID: 39186181 [Abstract] [Full Text] [Related]
16. Evaluation of the Usage and Dosing of Guideline-Directed Medical Therapy for Heart Failure With Reduced Ejection Fraction Patients in Clinical Practice. Smith KV, Dunning JR, Fischer CM, MacLean TE, Bosque-Hamilton JW, Fera LE, Grant JY, Zelle DJ, Matta L, Gaziano TA, MacRae CA, Scirica BM, Desai AS. J Pharm Pract; 2022 Oct 22; 35(5):747-751. PubMed ID: 33813934 [Abstract] [Full Text] [Related]
17. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study. Teng TK, Tromp J, Tay WT, Anand I, Ouwerkerk W, Chopra V, Wander GS, Yap JJ, MacDonald MR, Xu CF, Chia YM, Shimizu W, ASIAN-HF investigators, Richards AM, Voors A, Lam CS. Lancet Glob Health; 2018 Sep 22; 6(9):e1008-e1018. PubMed ID: 30103979 [Abstract] [Full Text] [Related]
18. Guideline-directed medical therapy in real-world heart failure patients with low blood pressure and renal dysfunction. Chen X, Cui X, Thunström E, Pivodic A, Dahlström U, Fu M. Clin Res Cardiol; 2021 Jul 22; 110(7):1051-1062. PubMed ID: 33394127 [Abstract] [Full Text] [Related]